278 related articles for article (PubMed ID: 34044345)
1. Bifunctional chiral selenium-containing 1,4-diarylazetidin-2-ones with potent antitumor activities by disrupting tubulin polymerization and inducing reactive oxygen species production.
Tang H; Liang Y; Cheng J; Ding K; Wang Y
Eur J Med Chem; 2021 Oct; 221():113531. PubMed ID: 34044345
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antitumor evaluation of novel chiral diaryl substituted azetidin-2-one derivatives as tubulin polymerization inhibitors.
Liang Y; Zhang M; Zhou P; Liu M; Li J; Wang Y
Bioorg Chem; 2021 Oct; 115():105239. PubMed ID: 34399321
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect.
Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937
[TBL] [Abstract][Full Text] [Related]
5. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a chiral fluorinated azetidin-2-one as a tubulin polymerisation inhibitor with potent antitumour efficacy.
Tang H; Cheng J; Liang Y; Wang Y
Eur J Med Chem; 2020 Jul; 197():112323. PubMed ID: 32339854
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Biochemical Evaluation of 3-Phenoxy-1,4-diarylazetidin-2-ones as Tubulin-Targeting Antitumor Agents.
Greene TF; Wang S; Greene LM; Nathwani SM; Pollock JK; Malebari AM; McCabe T; Twamley B; O'Boyle NM; Zisterer DM; Meegan MJ
J Med Chem; 2016 Jan; 59(1):90-113. PubMed ID: 26680364
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel tubulin/HDAC dual-targeting inhibitors with strong antitumor and antiangiogenic potency.
Wang Y; Sun M; Wang Y; Qin J; Zhang Y; Pang Y; Yao Y; Yang H; Duan Y
Eur J Med Chem; 2021 Dec; 225():113790. PubMed ID: 34454126
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of new 2-chloro-4-aminopyrimidine and 2,6-dimethyl-4-aminopyrimidine derivatives as tubulin polymerization inhibitors.
Xu S; An B; Li Y; Luo X; Li X; Jia X
Bioorg Med Chem Lett; 2018 Jun; 28(10):1769-1775. PubMed ID: 29673981
[TBL] [Abstract][Full Text] [Related]
11. Novel diaryl-2H-azirines: Antitumor hybrids for dual-targeting tubulin and DNA.
Lin S; Liang Y; Cheng J; Pan F; Wang Y
Eur J Med Chem; 2021 Mar; 214():113256. PubMed ID: 33581556
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer activity and molecular docking studies on 1,2-diarylbenzimidazole analogues as anti-tubulin agents.
Zhang YL; Yang R; Xia LY; Man RJ; Chu YC; Jiang AQ; Wang ZC; Zhu HL
Bioorg Chem; 2019 Nov; 92():103219. PubMed ID: 31476616
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of vinyl selenone derivatives as novel microtubule polymerization inhibitors.
Zhu H; Sun H; Liu Y; Duan Y; Liu J; Yang X; Li W; Qin S; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2020 Dec; 207():112716. PubMed ID: 32853870
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
15. Identification of gallic acid based glycoconjugates as a novel tubulin polymerization inhibitors.
Upadhyaya K; Hamidullah ; Singh K; Arun A; Shukla M; Srivastava N; Ashraf R; Sharma A; Mahar R; Shukla SK; Sarkar J; Ramachandran R; Lal J; Konwar R; Tripathi RP
Org Biomol Chem; 2016 Jan; 14(4):1338-58. PubMed ID: 26659548
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis of combretastatin A-4 piperazine derivatives as potential antitumor agents by inhibiting tubulin polymerization and inducing autophagy in HCT116 cells.
Zhang H; Li M; Zhou X; Tang L; Chen G; Zhang Y
Eur J Med Chem; 2024 Jun; 272():116497. PubMed ID: 38759453
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
[TBL] [Abstract][Full Text] [Related]
19. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
[TBL] [Abstract][Full Text] [Related]
20. A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.
Zhang YL; Li BY; Yang R; Xia LY; Fan AL; Chu YC; Wang LJ; Wang ZC; Jiang AQ; Zhu HL
Eur J Med Chem; 2019 Feb; 163():896-910. PubMed ID: 30580241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
